购物车
- 全部删除
- 您的购物车当前为空
HDAC1/CDK7-IN-1(compound 8e)是一款针对CDK7和HDAC1的双重抑制剂,其IC50值分别为893 nM 和248 nM 。该化合物能有效抑制MDA-MB-231、MCF-7、A549及HCT-116等多种癌细胞系的生长。此外,HDAC1/CDK7-IN-1在HCT-116细胞中诱发了细胞周期阻滞与凋亡(apoptosis)现象,并能够抑制其细胞迁移能力。
HDAC1/CDK7-IN-1(compound 8e)是一款针对CDK7和HDAC1的双重抑制剂,其IC50值分别为893 nM 和248 nM 。该化合物能有效抑制MDA-MB-231、MCF-7、A549及HCT-116等多种癌细胞系的生长。此外,HDAC1/CDK7-IN-1在HCT-116细胞中诱发了细胞周期阻滞与凋亡(apoptosis)现象,并能够抑制其细胞迁移能力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 8-10周 | |
50 mg | 询价 | 8-10周 |
产品描述 | HDAC1/CDK7-IN-1 (compound 8e) serves as a dual inhibitor targeting both CDK7 and HDAC1, with IC50 values of 893 nM and 248 nM , respectively. This compound effectively suppresses the proliferation of various cancer cell lines, including MDA-MB-231, MCF-7, A549, and HCT-116. Additionally, it triggers cell cycle arrest and apoptosis in HCT-116 cells and impedes their migration [1]. |
分子量 | 626.11 |
分子式 | C33H32ClN7O4 |
CAS No. | 2987905-95-1 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容